Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis
- PMID: 7698710
- PMCID: PMC1382466
- DOI: 10.1136/gut.36.3.459
Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis
Abstract
A 17 year old Asian patient with autoimmune chronic active hepatitis resistant to treatment with high dose corticosteroids and azathioprine was given cyclosporin at a dose of 5 mg/kg/day. Within two weeks of starting the cyclosporin treatment a favourable clinical and biochemical response was obtained and by one month serum aminotransferase activities were within normal limits. An attempted reduction in the daily dose of cyclosporin resulted in a relapse of the patient's disease. Remission was again attained by returning the dose of cyclosporin to 5 mg/kg/day. No significant side effects of the treatment have been shown. Cyclosporin seems to have a role in the treatment of corticosteroid resistant autoimmune chronic active hepatitis and its further evaluation is warranted.
Similar articles
-
Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.Hepatology. 1988 Jul-Aug;8(4):781-4. doi: 10.1002/hep.1840080414. Hepatology. 1988. PMID: 3292363 Clinical Trial.
-
Cyclosporine treatment of autoimmune chronic active hepatitis.Gastroenterology. 1987 Oct;93(4):890-3. doi: 10.1016/0016-5085(87)90454-9. Gastroenterology. 1987. PMID: 2887482
-
Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.J Hepatol. 1994 Dec;21(6):1040-7. doi: 10.1016/s0168-8278(05)80615-4. J Hepatol. 1994. PMID: 7699225
-
Therapeutic strategies for autoimmune hepatitis.Dig Dis. 2011;29(4):411-5. doi: 10.1159/000329805. Epub 2011 Aug 30. Dig Dis. 2011. PMID: 21894012 Review.
-
[Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases].Z Rheumatol. 1995 Mar-Apr;54(2):89-95. Z Rheumatol. 1995. PMID: 7793161 Review. German.
Cited by
-
Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis: Interim Analysis Report of a Randomized Controlled Trial.Middle East J Dig Dis. 2013 Oct;5(4):193-200. Middle East J Dig Dis. 2013. PMID: 24829691 Free PMC article.
-
Drug therapy in the management of type 1 autoimmune hepatitis.Drugs. 1999 Jan;57(1):49-68. doi: 10.2165/00003495-199957010-00005. Drugs. 1999. PMID: 9951951 Review.
-
Difficult treatment decisions in autoimmune hepatitis.World J Gastroenterol. 2010 Feb 28;16(8):934-47. doi: 10.3748/wjg.v16.i8.934. World J Gastroenterol. 2010. PMID: 20180231 Free PMC article. Review.
-
Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease.J Clin Transl Hepatol. 2013 Dec;1(2):79-86. doi: 10.14218/JCTH.2013.00015. Epub 2013 Dec 15. J Clin Transl Hepatol. 2013. PMID: 26356124 Free PMC article. Review.
-
Treatment of autoimmune liver disease: current and future therapeutic options.Ther Adv Chronic Dis. 2013 May;4(3):119-41. doi: 10.1177/2040622313478646. Ther Adv Chronic Dis. 2013. PMID: 23634279 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources